M. E. Kalland

发表

Human Naturally Occurring and Adaptive Regulatory T cells Secrete High Levels of Leukaemia Inhibitory Factor upon Activation

K. Torgersen, E. Aandahl, K. Taskén, 2008, Scandinavian journal of immunology.

Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG.

K. Taskén, T. Berge, S. Skånland, 2012, Experimental cell research.

High-resolution mapping of prostaglandin E 2 –dependent signaling networks identiﬁes a constitutively active PKA signaling node in CD8 (cid:1) CD45RO (cid:1) T cells

S. Lemeer, A. Heck, K. Torgersen, 2010 .

The European Medicines Agency Review of Kymriah (Tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukemia and Diffuse Large B-Cell Lymphoma.

J. Bergh, C. Gisselbrecht, I. Buajordet, 2019, The oncologist.

High-resolution mapping of prostaglandin E2-dependent signaling networks identifies a constitutively active PKA signaling node in CD8+CD45RO+ T cells.

Albert J R Heck, Simone Lemeer, S. Lemeer, 2010, Blood.

T Cell-Signaling Network Analysis Reveals Distinct Differences between CD28 and CD2 Costimulation Responses in Various Subsets and in the MAPK Pathway between Resting and Activated Regulatory T Cells

K. Torgersen, K. Taskén, T. Vang, 2011, The Journal of Immunology.

Quantitative profiling of tyrosine phosphorylation revealed changes in the activity of the T cell receptor signaling pathway upon cisplatin-induced apoptosis.

K. Taskén, M. Arntzen, B. Thiede, 2013, Journal of proteomics.

Licensing of Orphan Medicinal Products—Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021

Frauke Naumann-Winter, U. Hermes, A. Magrelli, 2022, Frontiers in Pharmacology.

Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit–The EU Regulator's Perspective

S. Tsigkos, Maria E Sheean, S. Mariz, 2021, Frontiers in Medicine.